Stockscreener 앱 받기
9.24
0.43%
-0.04
시간 외 거래:
9.24
전일 마감가:
$9.28
열려 있는:
$9.2
하루 거래량:
564.70K
Relative Volume:
0.63
시가총액:
$706.39M
수익:
$54.55M
순이익/손실:
$-193.57M
주가수익비율:
-3.1972
EPS:
-2.89
순현금흐름:
$-181.86M
1주 성능:
+12.14%
1개월 성능:
-1.07%
6개월 성능:
-22.22%
1년 성능:
-58.88%
1일 변동 폭
$9.09
$9.41
1주일 범위
$8.20
$9.41
52주 변동 폭
$8.18
$29.56
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.24 | 709.45M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 개시 | Leerink Partners | Market Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | Jefferies | Buy |
| 2024-09-06 | 재개 | Robert W. Baird | Outperform |
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
Technical analysis overview for Nurix Therapeutics Inc. stock2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com
How Nurix Therapeutics Inc. stock performs in weak economyMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
Subdued Growth No Barrier To Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Price - simplywall.st
Does Nurix Therapeutics Inc. qualify in momentum factor screeningWeekly Profit Summary & Weekly Momentum Picks - newser.com
What momentum shifts mean for Nurix Therapeutics Inc.Earnings Miss & Real-Time Sentiment Analysis - newser.com
What drives Nurix Therapeutics Inc stock priceCovered Call Writing & Fast Growing Portfolio Trading - earlytimes.in
Nurix Therapeutics Inc.’s volatility index tracking explainedPortfolio Value Report & Verified Short-Term Trading Plans - newser.com
Nurix Therapeutics Inc. stock trend forecastPortfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
Using Bollinger Bands to evaluate Nurix Therapeutics Inc.Day Trade & Reliable Breakout Stock Forecasts - newser.com
Using AI based signals to follow Nurix Therapeutics Inc.Wall Street Watch & Verified Technical Signals - newser.com
What analysts say about Nurix Therapeutics Inc stockGrowth vs. Value Investing & Free Trading Psychology Coaching - earlytimes.in
What margin trends mean for Nurix Therapeutics Inc. stockWeekly Risk Summary & Smart Allocation Stock Reports - newser.com
What MACD and RSI say about Nurix Therapeutics Inc.Trade Risk Assessment & Expert Curated Trade Setups - newser.com
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 4.6%Time to Buy? - MarketBeat
Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - Yahoo Finance
RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
Nurix Therapeutics, Inc. (NRIX) Reports Q3 Loss, Lags Revenue Estimates - MSN
Nurix Therapeutics’ SWOT analysis: promising pipeline drives biotech stock outlook - Investing.com Nigeria
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 6.5%Should You Buy? - MarketBeat
Aug Final Week: Is Nurix Therapeutics Inc forming a double bottomProduct Launch & Low Drawdown Trading Strategies - خودرو بانک
Goldman Sachs Group Inc. Has $6.03 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Is Nurix Therapeutics Inc stock good for income investorsMarket Weekly Review & Fast Gain Stock Trading Tips - khodrobank.com
Published on: 2025-09-19 19:28:52 - خودرو بانک
Growth Value: Can Nurix Therapeutics Inc scale operations efficientlyTrade Analysis Summary & AI Forecasted Entry and Exit Points - خودرو بانک
Market Recap: Is Telefnica Brasil SA Depositary Receipts ROE strong enoughSell Signal & Reliable Trade Execution Plans - khodrobank.com
Published on: 2025-09-19 16:56:26 - خودرو بانک
Nurix Therapeutics (NRIX) Receives a Buy from Stifel Nicolaus - The Globe and Mail
What candlestick patterns are forming on Nurix Therapeutics Inc.Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com
Nurix Therapeutics (NRIX) Gets a Buy from Barclays - The Globe and Mail
Can volume confirm reversal in Nurix Therapeutics Inc.2025 Big Picture & Real-Time Price Movement Reports - newser.com
Using Ichimoku Cloud for Nurix Therapeutics Inc. technicalsWeekly Profit Analysis & Smart Allocation Stock Reports - newser.com
Predicting Nurix Therapeutics Inc. trend using moving averagesPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - newser.com
US Market Recap: Is Nurix Therapeutics Inc forming a double bottomJuly 2025 Rallies & Weekly Market Pulse Alerts - خودرو بانک
Aug Reactions: Whats the RSI of Nurix Therapeutics Inc stockJuly 2025 Decliners & Trade Opportunity Analysis Reports - خودرو بانک
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛
Barclays Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $31 - 富途牛牛
Smart tools for monitoring Nurix Therapeutics Inc.’s price actionWeekly Profit Report & Accurate Buy Signal Notifications - newser.com
Short interest data insights for Nurix Therapeutics Inc.July 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
Using RSI to spot recovery in Nurix Therapeutics Inc.Weekly Risk Summary & AI Enhanced Trading Signals - newser.com
Nurix Therapeutics Inc. recovery potential after sell offTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com
Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis - Investing News Network
Nurix Therapeutics Advances GS-6791 into Clinical Testing for Inflammatory Diseases with Preclinical Data Presented at EADV Congress - Quiver Quantitative
Near-Complete IRAK4 Knockdown: Nurix's Novel Dermatitis Drug Shows Breakthrough Results in Preclinical Study - Stock Titan
Pattern recognition hints at Nurix Therapeutics Inc. upsideTreasury Yields & Technical Analysis for Trade Confirmation - newser.com
Aug Volume: Should I buy Nurix Therapeutics Inc stock nowWeekly Profit Recap & Weekly Chart Analysis and Trade Guides - خودرو بانک
Earnings Report: Is Nurix Therapeutics Inc. stock good for income investorsWeekly Trade Recap & Fast Exit/Entry Strategy Plans - خودرو بانک
Aug Summary: What is the long term forecast for Nurix Therapeutics Inc stock2025 Investor Takeaways & Daily Profit Maximizing Tips - خودرو بانک
Inflation Data: Is Nurix Therapeutics Inc a stock for growth or value investorsJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - خودرو بانک
Price action breakdown for Nurix Therapeutics Inc.2025 Market Outlook & Proven Capital Preservation Tips - newser.com
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):